Leah Rand

Leah Rand, DPhil

Lecturer on Medicine, Brigham and Women's Hospital
Research Scientist, PORTAL at BWH
Affiliate, HMS Center for Bioethics

Leah Rand, DPhil, is a Research Scientist with the Program on Regulation, Therapeutics, and Law (PORTAL) at Brigham and Women's Hospital. She teaches Foundations of Bioethics for the MBE program and leads a Capstone seminar and the Health Policy & Bioethics Consortia.

Her work focuses on prescription drug pricing policy with a particular focus on fair pricing, health technology assessment, and healthcare access. She also works on ethical issues in public trust of regulators. Prior to joining PORTAL, Leah staffed a consensus study at the National Academies of Sciences, Engineering, and Medicine on public health emergency preparedness and response where she also contributed to writing a framework of ethical considerations for innovative biomedical technologies. She has published on quality-adjusted life years, prescription drug price negotiations, ethical issues in health technology assessment, patient and public involvement in research and health technology appraisal. Leah graduated from the University of Chicago and received an MA in philosophy from University College London, where she was a Marshall Scholar, and a doctorate in applied ethics from the University of Oxford.

Publications View
International reference pricing for prescription drugs: a landscape analysis.
Authors: Authors: Rand LZ, Kesselheim AS.
J Manag Care Spec Pharm
View full abstract on Pubmed
Controversy Over Using Quality-Adjusted Life-Years In Cost-Effectiveness Analyses: A Systematic Literature Review.
Authors: Authors: Rand LZ, Kesselheim AS.
Health Aff (Millwood)
View full abstract on Pubmed
International Reference Pricing for Prescription Drugs in the United States: Administrative Limitations and Collateral Effects.
Authors: Authors: Rand LZ, Kesselheim AS.
Value Health
View full abstract on Pubmed
Public involvement in the governance of population-level biomedical research: unresolved questions and future directions.
Authors: Authors: Erikainen S, Friesen P, Rand L, Jongsma K, Dunn M, Sorbie A, McCoy M, Bell J, Burgess M, Chen H, Chico V, Cunningham-Burley S, Darbyshire J, Dawson R, Evans A, Fahy N, Finlay T, Frith L, Goldenberg A, Hinton L, Hoppe N, Hughes N, Koenig B, Lignou S, McGowan M, Parker M, Prainsack B, Shabani M, Staunton C, Thompson R, Varnai K, Vayena E, Williams O, Williamson M, Chan S, Sheehan M.
J Med Ethics
View full abstract on Pubmed
An International Review of Health Technology Assessment Approaches to Prescription Drugs and Their Ethical Principles.
Authors: Authors: Rand LZ, Kesselheim AS.
J Law Med Ethics
View full abstract on Pubmed
Are Medicaid Closed Formularies Unethical?
Authors: Authors: Rand L, Persad G.
AMA J Ethics
View full abstract on Pubmed
Patient and public involvement: Two sides of the same coin or different coins altogether?
Authors: Authors: McCoy MS, Warsh J, Rand L, Parker M, Sheehan M.
Bioethics
View full abstract on Pubmed
Disentangling Evidence and Preference in Patient-Clinician Concordance Discussions.
Authors: Authors: Rand LZG, Berger Z.
AMA J Ethics
View full abstract on Pubmed
Understanding and using patient experiences as evidence in healthcare priority setting.
Authors: Authors: Rand L, Dunn M, Slade I, Upadhyaya S, Sheehan M.
Cost Eff Resour Alloc
View full abstract on Pubmed
National Standards for Public Involvement in Research: missing the forest for the trees.
Authors: Authors: McCoy MS, Jongsma KR, Friesen P, Dunn M, Neuhaus CP, Rand L, Sheehan M.
J Med Ethics
View full abstract on Pubmed